Table 3 Risk of COVID-19 among individuals with neurodegenerative diseases, by time since the first diagnosis, compared to individuals without such conditions
No.(%)of Any COVID-19 | Odds Ratio | No.(%)of Inpatient COVID-19 | Odds Ratio | No.(%)of COVID-19 related death | Odds Ratio | ||||
|---|---|---|---|---|---|---|---|---|---|
Exposed | Unexposed | (95% CI) | Exposed | Unexposed | (95% CI) | Exposed | Unexposed | (95% CI) | |
Time since the first diagnosis of neurodegenerative diseases, years | |||||||||
< 1 | 82/309 (26.5) | 17,220/93658 (18.4) | 2.56 (1.97–3.32) | 49/309 (15.9) | 5370/93658 (5.7) | 2.45 (1.79–3.36) | 19/309 (6.1) | 986/93658 (1.1) | 2.81 (1.73–4.57) |
1–2 | 289/1009 (28.6) | 2.70 (2.34–3.12) | 158/1009 (15.7) | 2.37 (1.98–2.83) | 84/1009 (8.3) | 3.92 (3.08–5.01) | |||
3–4 | 145/549 (26.4) | 2.42 (1.99–2.95) | 72/549 (13.1) | 1.95 (1.51–2.51) | 49/549 (8.9) | 4.45 (3.25–6.09) | |||
≥ 5 | 202/750 (26.9) | 2.27 (1.92–2.68) | 100/750 (13.3) | 1.99 (1.60–2.47) | 43/750 (5.7) | 2.89 (2.08–4.00) | |||